NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington’s Disease

Press Release Sep 7, 2021

Using NeuExcell’s neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington’s Disease. Spark Therapeutic’s excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform may advance the development […]

NeuExcell Therapeutics names Russ Addis as Vice President, Research

Press Release Aug 23, 2021

August 23, 2021. State College, Pennsylvania – NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief […]

Tag: NeuExcell

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington’s Disease

NeuExcell Therapeutics names Russ Addis as Vice President, Research

Cookies & Privacy